Strides Pharma Science Limited (STAR.BO) Stock Analysis & Winston Score

Strides Pharma Science is an Indian pharmaceutical company that makes generic medicines — affordable versions of brand-name drugs. It focuses on products like capsules, tablets, and oral liquids, selling mainly to pharmacies, hospitals, and distributors. The company is one of India's notable generic drugmakers with a strong presence in regulated markets like the United States, Australia, and parts of Africa. Strides earns revenue by manufacturing and selling finished-dose generic pharmaceuticals, often through partnerships and its own distribution channels. It operates manufacturing facilities in India and other countries that are approved by regulators like the US FDA. Its competitive edge comes from a broad product portfolio and the ability to file drug approvals across multiple geographies simultaneously. Key growth depends on expanding its US generics pipeline and maintaining regulatory compliance, while pricing pressure in the generic drug market remains an ongoing risk.